Back to search

Article

Main protease mutants of SARS-CoV-2 variants remain susceptible to nirmatrelvir (PF-07321332)

2021-11-30

Abstract excerpt

The COVID-19 pandemic continues to be a public health threat. Multiple mutations in the spike protein of emerging variants of SARS-CoV-2 appear to impact on the effectiveness of available vaccines. Specific antiviral agents are keenly anticipated but their efficacy may also be compromised in emerging variants. One of the most attractive coronaviral drug targets is the main protease (M pro ). A promising M pro in...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9e45dbd4-df55-5dd7-aa84-c84f33fad6ed
DOI
10.1101/2021.11.28.470226
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Main protease mutants of SARS-CoV-2 variants remain susceptible to nirmatrelvir (PF-07321332)DOI 10.1101/2021.11.28.470226
Select a neighboring publication to make it the new centre.